293 related articles for article (PubMed ID: 11993707)
1. The Histologic Spectrum of Apocrine Lesions of the Breast.
Durham JR; Fechner RE
Am J Clin Pathol; 2000 May; 113(suppl_1):S3-18. PubMed ID: 11993707
[TBL] [Abstract][Full Text] [Related]
2. Apocrine ductal carcinoma in situ involving a sclerosing lesion with adenosis: report of a case.
Visscher DW
Arch Pathol Lab Med; 2009 Nov; 133(11):1817-21. PubMed ID: 19886717
[TBL] [Abstract][Full Text] [Related]
3. Non-operative breast pathology: apocrine lesions.
Wells CA; El-Ayat GA
J Clin Pathol; 2007 Dec; 60(12):1313-20. PubMed ID: 18042688
[TBL] [Abstract][Full Text] [Related]
4. The spectrum of apocrine lesions of the breast.
O'Malley FP; Bane AL
Adv Anat Pathol; 2004 Jan; 11(1):1-9. PubMed ID: 14676636
[TBL] [Abstract][Full Text] [Related]
5. The histologic spectrum of apocrine breast proliferations: a comparative study of morphology and DNA content by image analysis.
Raju U; Zarbo RJ; Kubus J; Schultz DS
Hum Pathol; 1993 Feb; 24(2):173-81. PubMed ID: 8381766
[TBL] [Abstract][Full Text] [Related]
6. Surgical follow-up results for apocrine adenosis and atypical apocrine adenosis diagnosed on breast core biopsy.
Hou Y; Chaudhary S; Gao FF; Li Z
Ann Diagn Pathol; 2016 Oct; 24():4-6. PubMed ID: 27649945
[TBL] [Abstract][Full Text] [Related]
7. CD10 Immunohistochemical Expression in Apocrine Lesions of the Breast.
Kővári B; Báthori Á; Cserni G
Pathobiology; 2015; 82(6):259-63. PubMed ID: 26562027
[TBL] [Abstract][Full Text] [Related]
8. Atypical Apocrine Adenosis: Diagnostic Challenges and Pitfalls.
Asirvatham JR; Falcone MM; Kleer CG
Arch Pathol Lab Med; 2016 Oct; 140(10):1045-51. PubMed ID: 27684975
[TBL] [Abstract][Full Text] [Related]
9. Cell turnover in apocrine metaplasia and apocrine adenosis of the breast.
Elayat G; Selim AG; Wells CA
Ann Diagn Pathol; 2010 Feb; 14(1):1-7. PubMed ID: 20123450
[TBL] [Abstract][Full Text] [Related]
10. Intraductal proliferations of the breast: a review of histologic criteria for atypical intraductal hyperplasia and ductal carcinoma in situ, including apocrine and papillary lesions.
Purcell CA; Norris HJ
Ann Diagn Pathol; 1998 Apr; 2(2):135-45. PubMed ID: 9845731
[TBL] [Abstract][Full Text] [Related]
11. Upgrade Rate and Imaging Features of Atypical Apocrine Lesions.
Chang Sen LQ; Berg WA; Carter GJ
Breast J; 2017 Sep; 23(5):569-578. PubMed ID: 28333404
[TBL] [Abstract][Full Text] [Related]
12. Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts: a lesion associated with tubular carcinoma.
Goldstein NS; O'Malley BA
Am J Clin Pathol; 1997 May; 107(5):561-6. PubMed ID: 9128269
[TBL] [Abstract][Full Text] [Related]
13. Extratumoral breast tissue in breast cancer patients: a multinational study of variations with age and country of residence in low- and high-risk countries. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Aaman TB; Stalsberg H; Thomas DB
Int J Cancer; 1997 May; 71(3):333-9. PubMed ID: 9139863
[TBL] [Abstract][Full Text] [Related]
14. Apocrine lesions of the breast: part 1 of a two-part review: benign, atypical and in situ apocrine proliferations of the breast.
D'Arcy C; Quinn C
J Clin Pathol; 2019 Jan; 72(1):1-6. PubMed ID: 30409840
[TBL] [Abstract][Full Text] [Related]
15. Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.
Celis JE; Moreira JM; Gromova I; Cabezón T; Gromov P; Shen T; Timmermans V; Rank F
Mol Oncol; 2007 Jun; 1(1):97-119. PubMed ID: 19383289
[TBL] [Abstract][Full Text] [Related]
16. Massive myoepithelial proliferation (myoepitheliosis) with lumpy deposits of basement membrane material closely associated with apocrine adenosis and ductal carcinoma in situ of the breast.
Kawasaki T; Oyama T; Nakagomi H; Furuya K; Kondo T; Nakazawa T; Mochizuki K; Yamane T; Miyazawa T; Ishii Y; Fukushima K; Moriya T; Tsunoda H; Katoh R
Pathol Int; 2011 Oct; 61(10):615-7. PubMed ID: 21951673
[No Abstract] [Full Text] [Related]
17. Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast.
Tramm T; Kim JY; Tavassoli FA
Am J Surg Pathol; 2011 Feb; 35(2):202-11. PubMed ID: 21263240
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-kit in common benign and malignant breast lesions.
Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostics of benign ductal epithelial cell proliferation of the breast in biopsy material].
Sinn HP; Flechtenmacher C; Aulmann S
Pathologe; 2014 Feb; 35(1):18-25. PubMed ID: 24448666
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
Gatalica Z
Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
